RecruitingNCT02055105
Modulation of Molecular Fingerprinting in Pediatric Sepsis
Sponsor
Phoenix Children's Hospital
Enrollment
50 participants
Start Date
Mar 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.
Eligibility
Min Age: 1 YearMax Age: 18 Years
Inclusion Criteria4
- Age 1 through 18 years
- Patients admitted to the PICU with concerns for sepsis or those developing sepsis during their admission to the hospital.
- Patients must be enrolled int he study from arrival time tot he ED up to 24 hours from the time of initiation of antibiotic therapy for treatment of sepsis or septic shock.
- Signed informed consent.
Exclusion Criteria1
- Patients <1 year of age and greater than 18 years of age.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREmiRNA in Sepsis
miRNA in Sepsis
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02055105
Related Trials
Determinants of Vascular Leakage During Systemic Inflammatory Response Syndrome
NCT056632162 locations
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
NCT019041882 locations
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure
NCT0403322415 locations
Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)
NCT045806801 location
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)
NCT060524361 location